These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12732108)

  • 1. [Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?].
    Calvet X; Gené E
    Gastroenterol Hepatol; 2003 May; 26(5):325-9. PubMed ID: 12732108
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
    Kanayama S
    Nihon Rinsho; 1999 Jan; 57(1):153-6. PubMed ID: 10036954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
    Marchi S; Costa F; Bellini M; Belcari C; Mumolo MG; Tornar A; Spisni R; Torelli E; Maltinti G
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):547-50. PubMed ID: 11396535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
    Peterson WL
    Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():21-5. PubMed ID: 9146787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for anti-ulcer drugs in adults].
    Chassany O
    Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038
    [No Abstract]   [Full Text] [Related]  

  • 11. Helicobacter pylori eradication: therapy other than with bismuth or proton-pump inhibitors.
    Korman MG
    Scand J Gastroenterol Suppl; 1996; 220():41-3. PubMed ID: 8898434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
    Gisbert JP
    Gastroenterol Hepatol; 2005 Nov; 28(9):567-75. PubMed ID: 16277966
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel therapeutic approaches to the management of Helicobacter pylori infection.
    Montague S; O'Morain CA
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S334-8. PubMed ID: 10077769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of gastritis-associated Helicobacter pylori infection in children].
    Velasco Benítez CA; Amorocho Pérez RD
    Rev Gastroenterol Peru; 2002; 22(2):159-63. PubMed ID: 12098744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Helicobacter pylori infection. Triple regimen based on ranitidine bismuth citrate could be solution.
    Savarino V; Neri M; Vigneri S
    BMJ; 2000 Jun; 320(7248):1541. PubMed ID: 10877585
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice.
    Medhi B; Prakash A
    Scand J Gastroenterol; 2008 Aug; 43(8):1022-3; author reply 1024. PubMed ID: 19086171
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent eradication of Helicobacter pylori with dual therapy.
    Treiber G; Ammon S; Klotz U
    Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
    Graham DY; Hammoud F; El-Zimaity HM; Kim JG; Osato MS; El-Serag HB
    Aliment Pharmacol Ther; 2003 May; 17(10):1229-36. PubMed ID: 12755836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
    Catalano F; Branciforte G; Catanzaro R; Cipolla R; Bentivegna C; Brogna A
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1329-34. PubMed ID: 11012478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.